Biocept
BIOC
$0.43
Share price
0.00%
Change (1 day)
-95.74%
Change (1 year)
Categories
Operating Margin for Biocept (BIOC)
Operating Margin as of May 2024 (TTM): -124.57%
According to Biocept 's latest financial reports and stock price the company's current Operating Margin is -124.57%. At the end of 2021 the company had an Operating Margin of -4.41%.
Operating Margin history for Biocept from 2013 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -4.41% | -93.2% |
| 2020 | -64.84% | -85.74% |
| 2019 | -454.69% | -39.85% |
| 2018 | -755.92% | 77.33% |
| 2017 | -426.27% | -25.32% |
| 2016 | -570.79% | -79.46% |
| 2015 | -2,778.76% | -76.63% |
| 2014 | -11,891.12% | 72.9% |
| 2013 | -6,877.26% | -38.69% |
| 2012 | -11,216.80% | -99.13% |
| 2011 | -1,295,483.46% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | -11.67% | -90.63% | 🇺🇸 USA |
 Exact Sciences EXAS | -30.34% | -75.64% | 🇺🇸 USA |
 Myriad Genetics MYGN | -20.72% | -83.37% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.